
Fenofibrate
Hypercholesterolaemia, Hypertriglyceridaemia
160 · 200mg
Fenofibrate 160 mg and 200 mg, a fibrate that lowers triglycerides and raises HDL cholesterol, the ingredient in Lipidil.
Fenofibrate (Tricor) is a lipid-regulating medication used to manage high levels of triglycerides and cholesterol. It serves as a standard treatment option to support cardiovascular health markers. It is listed here as Fenofibrate in 160 mg and 200 mg strengths.

Hypercholesterolaemia, Hypertriglyceridaemia
160 · 200mg
Fenofibrate 160 mg and 200 mg, a fibrate that lowers triglycerides and raises HDL cholesterol, the ingredient in Lipidil.
Fenofibrate belongs to the fibrate class of medications. It acts primarily in the liver to control how the body processes fats and cholesterol. By altering these metabolic pathways, it supports healthier lipid profiles in the bloodstream. Because diverse formulations and strengths exist to meet varying clinical requirements, multiple brands are available.
Fenofibrate is used for the management of Hypertriglyceridaemia and Mixed Dyslipidaemia. It is often selected when lifestyle modifications, such as dietary adjustments and exercise, have not sufficed in reaching target lipid levels. This medication addresses the underlying chemical imbalance rather than just the symptoms.
This medicine works by activating a protein receptor called PPAR-alpha. Activation of this receptor increases the breakdown of triglyceride-rich fats and improves the removal of these substances from the liver. By increasing the rate at which your body clears lipids and reducing the production of certain proteins, it balances cholesterol levels in the blood.
The brand range for this active compound includes options like Lipantil, Supralip, and the originator Tricor. These brands are commonly available as a Tablet. Choosing between brands often depends on the specific dosage strength your doctor has identified for your condition. It is a standard component of professional Cholesterol Management.
Ensure you are aware of your baseline liver and kidney function, as this medication is processed through these systems. Inform your provider if you have a history of gallbladder disease or pancreatitis.
Common reactions can involve gastrointestinal discomfort, such as nausea or abdominal pain. Some individuals may experience changes in muscle sensation. Monitor your physical response when starting a new course of treatment.
Combining this medication with other lipid-lowering agents requires cautious screening to avoid potential muscle-related reactions. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.
Last updated